Priovant Therapeutics is a clinical-stage biotechnology company focused on developing targeted therapies for patients with severe autoimmune diseases. The company operates in the biotechnology and biopharmaceutical sectors, pursuing research and clinical development to bring therapeutic options to patients with autoimmune conditions. The site presents Priovant as a U.S.-based organization dedicated to advancing treatments for autoimmune diseases.
No recent deals for this company.